Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities:
Net earnings	$ 48,957	$ 43,608
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation	8,413	8,619
Amortization	11,748	12,358
Deferred income taxes	24	11
Noncurrent employee benefits	(138)	232
Stock-based compensation expense	2,170	1,537
Changes in:
Receivables	(18,860)	(8,985)
Inventories	(16,207)	(5,685)
Payables	23,870	7,420
Prepaid expenses and other assets	(9,405)	(11,648)
Other liabilities	2,171	12,967
Total adjustments	3,786	16,826
Net cash provided by operations	52,743	60,434
Investing activities:
Property, plant and equipment expenditures	(4,690)	(5,843)
Proceeds from company owned life insurance plans		596
Acquisitions, net of cash acquired		(45,273)
Net cash used for investing activities	(4,690)	(50,520)
Financing activities:
Dividends paid	(18,292)	(16,318)
Proceeds from exercise of stock options	61	2,037
Repurchase of treasury stock	(427)	(460)
Issuance of treasury stock		72
Net cash used for financing activities	(18,658)	(14,669)
Effect of foreign exchange rates on cash	(1,782)	(480)
(Decrease) Increase in cash and cash equivalents	27,613	(5,235)
Cash and cash equivalents - beginning of period	87,174	72,273
Cash and cash equivalents - end of period	$ 114,787	$ 67,038